Evolution and single-nucleotide polymorphisms in methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin and daptomycin, based on determination of the complete genome

Antimicrob Agents Chemother. 2015;59(6):3585-7. doi: 10.1128/AAC.05159-14. Epub 2015 Mar 16.

Abstract

We obtained a series of methicillin-resistant Staphylococcus aureus isolates, including both daptomycin-susceptible strain TD1 and daptomycin-resistant strain TD4, from a patient. We determined the complete genome sequences of TD1 and TD4 using next-generation sequencing, and only four single-nucleotide polymorphisms (SNPs) were identified, one each in capB (E58K), rpoB (H481Y), lytN (I16V), and mprF (V351E). We determined that these four SNPs were sufficient to cause the strains to develop daptomycin, vancomycin, and rifampin resistance.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Biological Evolution*
  • Daptomycin / pharmacology*
  • Gene Expression Regulation, Bacterial / genetics
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / genetics*
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Polymorphism, Single Nucleotide / genetics
  • Vancomycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Vancomycin
  • Daptomycin

Associated data

  • GENBANK/AP014652
  • GENBANK/AP014653